Robert A. Baffi

2020

In 2020, Robert A. Baffi earned a total compensation of $4.7M as Former President of Global Manufacturing and Technical Operations at BioMarin Pharmaceutical, a 28% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$443,300
Option Awards$810,197
Salary$637,115
Stock Awards$2,769,042
Other$29,047
Total$4,688,701

Baffi received $2.8M in stock awards, accounting for 59% of the total pay in 2020.

Baffi also received $443.3K in non-equity incentive plan, $810.2K in option awards, $637.1K in salary and $29K in other compensation.

Rankings

In 2020, Robert A. Baffi's compensation ranked 2,376th out of 13,090 executives tracked by ExecPay. In other words, Baffi earned more than 81.8% of executives.

ClassificationRankingPercentile
All
2,376
out of 13,090
82nd
Division
Manufacturing
911
out of 5,620
84th
Major group
Chemicals And Allied Products
324
out of 2,253
86th
Industry group
Drugs
275
out of 1,953
86th
Industry
Pharmaceutical Preparations
197
out of 1,458
87th

Pay ratio

Robert A. Baffi's Pay$4,688,701
Median Employee's Pay$181,141
Pay Ratio

26

to 1

In 2020, the annual total compensation of Robert A. Baffi was $4,688,701.

The annual total compensation of the median employee at BioMarin Pharmaceutical was $181,141.

The ratio of Robert A. Baffi's pay to the pay of median employee was therefore 26 to one.

Source: SEC filing on April 13, 2021.

Baffi's colleagues

We found six more compensation records of executives who worked with Robert A. Baffi at BioMarin Pharmaceutical in 2020.

2020

Jean-Jacques Bienaim

BioMarin Pharmaceutical

Chief Executive Officer

2020

Henry Fuchs

BioMarin Pharmaceutical

President, Worldwide R&D

2020

C Guyer

BioMarin Pharmaceutical

Chief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations

2020

Brian Mueller

BioMarin Pharmaceutical

Chief Financial Officer

2020

Jeff Ajer

BioMarin Pharmaceutical

Executive Vice President, Chief Commercial Officer

2020

Daniel Spiegelman

BioMarin Pharmaceutical

Chief Financial Officer

News

You may also like